BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10811095)

  • 21. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
    Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
    J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A follow-up of 130 patients with acromegaly in a single centre.
    Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK
    Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The volume of tumor mass and visual field defect in patients with pituitary macroadenoma.
    Lee JP; Park IW; Chung YS
    Korean J Ophthalmol; 2011 Feb; 25(1):37-41. PubMed ID: 21350693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acromegaly: a case report.
    Wells WL
    J Miss State Med Assoc; 1986 Jan; 27(1):9-11. PubMed ID: 3005588
    [No Abstract]   [Full Text] [Related]  

  • 25. Abnormalities of scanning laser polarimetry associated with pituitary adenoma.
    Tanito M; Itai N; Goto T; Ohira A; Chihara E
    Am J Ophthalmol; 2003 Apr; 135(4):565-7. PubMed ID: 12654388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours.
    Jadresic A; Banks LM; Child DF; Diamant L; Doyle FH; Fraser TR; Joplin GF
    Q J Med; 1982; 51(202):189-204. PubMed ID: 7111679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Consensus on the change of criteria for cure of acromegaly during the last decade].
    Kovács GL; Dénes J; Hubina E; Kovács L; Czirják S; Góth M
    Orv Hetil; 2011 May; 152(18):703-8. PubMed ID: 21498158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum growth hormone levels and size of pituitary tumour in untreated acromegaly.
    Wright AD; McLachlan MS; Doyle FH; Fraser TR
    Br Med J; 1969 Dec; 4(5683):582-4. PubMed ID: 5356545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual field defects in 23 acromegalic patients.
    Kan E; Kan EK; Atmaca A; Atmaca H; Colak R
    Int Ophthalmol; 2013 Oct; 33(5):521-5. PubMed ID: 23397103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective total removal of a growth-hormone-secreting adenoma: evidence that acromegaly is a primary pituitary disease.
    Wanski ZJ; Robinson AG; Jannetta PJ
    Metabolism; 1979 Jun; 28(6):624-8. PubMed ID: 221785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acromegaly and diabetes mellitus associated with hyperthyroidism.
    Deng D; Luo L; Chen M; Xu M; Wang Y
    Neuro Endocrinol Lett; 2014; 35(3):171-4. PubMed ID: 24977962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma.
    Gedik S; Gur S; Atalay B; Colak M; Altinors N; Akova YA
    Saudi Med J; 2007 Sep; 28(9):1380-4. PubMed ID: 17768464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of tangent screen, goldmann, and humphrey perimetry in the detection and localization of occipital lesions.
    Wong AM; Sharpe JA
    Ophthalmology; 2000 Mar; 107(3):527-44. PubMed ID: 10711892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current indications of stereotaxic interstitial irradiation in acromegaly. Ophthalmologic and neuroendocrinologic correlations in relation to prolonged time].
    Talairach J; Schaub C; Szikla G; Recoules D; Boujard O; Bleut-Pajot MT; Nassiet J; Lornet C
    Neurochirurgie; 1974; 20(4):369-90. PubMed ID: 4377577
    [No Abstract]   [Full Text] [Related]  

  • 35. Adolescent acromegaly: clinical parameters and treatment outcome.
    Bhansali A; Upreti V; Dutta P; Mukherjee KK; Nahar U; Santosh R; Das S; Walia R; Pathak A
    J Pediatr Endocrinol Metab; 2010 Oct; 23(10):1047-54. PubMed ID: 21158216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conservative management of pituitary macroadenoma contacting the optic apparatus.
    Ryu WH; Tam S; Rotenberg B; Labib MA; Lee D; Nicolle DA; Van Uum S; Duggal N
    Can J Neurol Sci; 2010 Nov; 37(6):837-42. PubMed ID: 21059548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary empty sella syndrome with visual field defects.
    Buckman MT; Husain M; Carlow TJ; Peake GT
    Am J Med; 1976 Jul; 61(1):124-8. PubMed ID: 937363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexistence of ectopic pituitary adenoma and empty sella in a patient with acromegaly : a case report and review of literature.
    Hong JF; Ding XH; Wang SS
    Neurol India; 2012; 60(3):304-6. PubMed ID: 22824688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of specific growth patterns and frequency of the empty sella phenomenon in growth hormone-secreting pituitary adenomas.
    Bier G; Hempel JM; Grimm F; Ernemann U; Bender B; Honegger J
    Eur J Radiol; 2018 Jul; 104():79-86. PubMed ID: 29857870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.
    Wijayaratne DR; Arambewela MH; Dalugama C; Wijesundera D; Somasundaram N; Katulanda P
    J Med Case Rep; 2015 Oct; 9():241. PubMed ID: 26514337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.